Clinical Trial: French Hypertrophic Cardiomyopathy Observatory

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: French Hypertrophic Cardiomyopathy Observatory

Brief Summary:

Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use.

The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)


Detailed Summary:

This both retrospective and prospective study is proposed to cardiology services 50 hospitals in France. A cardiologist referral is designated for each facility.

The following data will be collected by the physician during the initial hospitalization

  • Demographics
  • Geographic origin of patient
  • Clinical data: criteria for inclusion and non-inclusion data HCM general, Doppler ultrasound, personal history, family history
  • Reviews made: non-organic, biological
  • Family Survey,
  • Treatments: Medical, Electrical, invasive
  • Data from hospital

The follow-up to 18 months, 3 years and 5 years will be conducted by clinical-research-technicians of the French Society of Cardiology, an application will be made to municipalities of birth and mail a letter to physicians and patients.

The following data will be collected:

  • Vital status
  • Data from hospital
  • Reviews made: non-organic, biological
  • Treatments: Medical, Electrical, invasive

Sponsor: French Cardiology Society

Current Primary Outcome: Event-free survival [ Time Frame: 3 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Diagnostic methods [ Time Frame: 0 day ]

Define the profile of patients with HCM in France, diagnostic methods, evaluation (diagnostic investigation and family) and therapeutic. Who are the patients CMH France? (rules discovery, clinical presentation) and how are assumed the HCM in France? (examinations, hospitalizations, treatments, procedures for the family survey).


Original Secondary Outcome: Diagnostic methods [ Time Frame: 0 day ]

Define the profile of patients with MHC in France, diagnostic methods, evaluation (diagnostic investigation and family) and therapeutic. Who are the patients CMH France? (rules discovery, clinical presentation) and how are assumed the MHC in France? (examinations, hospitalizations, treatments, procedures for the family survey).


Information By: French Cardiology Society

Dates:
Date Received: March 8, 2010
Date Started: January 2010
Date Completion: December 2017
Last Updated: February 12, 2015
Last Verified: February 2015